Evidence map›Paper›PMID 35044204›Full record

ArticleJournal of clinical microbiology2022

Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department.

Evan J Beck, Yu-Hsiang Hsieh, Reinaldo E Fernandez, Gaby Dashler, Emily R Egbert, Shawn A Truelove, Caroline Garliss, Richard Wang, Evan M Bloch, Ruchee Shrestha and 10 more

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Long Covid Defined.The New England journal of medicine · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Evan J Beck *Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Yu-Hsiang Hsieh *Department of Emergency Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Reinaldo E FernandezDepartment of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Gaby DashlerDepartment of Emergency Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Emily R EgbertDepartment of Pediatrics, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Shawn A TrueloveDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Caroline GarlissDepartment of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Richard WangDepartment of Emergency Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Evan M BlochDepartment of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Ruchee ShresthaDepartment of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Joel BlanksonDepartment of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Andrea L CoxDepartment of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Yukari C ManabeDepartment of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Thomas KicklerDepartment of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Richard E RothmanDepartment of Emergency Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Andrew D ReddDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Aaron A R TobianDepartment of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Aaron M MilstoneDepartment of Pediatrics, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Thomas C QuinnDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Oliver LaeyendeckerDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-6429-4760

Funding

LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
HIV Prevention Trials Network: Network LaboratoryU01AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2006 to 2010
$16.5M
Unlocking the Potential of HIV-Infected Deceased Donors for Organ TransplantationR01AI120938 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TOBIAN, AARON A · 2016 to 2021
$4.3M
Penile Microbiome, Inflammation and HIV Susceptibility During Sexual Debut and Maturation Among Male AdolescentsR01AI128779 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TOBIAN, AARON A · 2017 to 2020
$2.1M
The Malaria Transfusion Risk (MATRix) StudyK23HL151826 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BLOCH, EVAN MARTIN · 2020 to 2024
$882k
Cost-Effectiveness of ED HIV Testing Program Agent-Based Modeling ApproachK01AI100681 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HSIEH, YU-HSIANG · 2012 to 2015
$532k
Epidemiologic and Immunologic Investigations of SARS-CoV-2 (COVID-19) InfectionsZIAAI001286 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI QUINN, THOMAS · 2020 to 2023
$349k
NHLBI NIH HHS K23 HL151826NIAID NIH HHS HHSN272201400007CNIAID NIH HHS K01 AI100681NIAID NIH HHS R01 AI120938NIAID NIH HHS R01 AI128779NIAID NIH HHS U01 AI068613NIAID NIH HHS UM1 AI068613
6 · The paper itself

Abstract

Emergency departments (EDs) can serve as surveillance sites for infectious diseases. The objective of this study was to determine the burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to monitor the prevalence of vaccination against coronavirus disease 2019 (COVID-19) among patients attending an urban ED in Baltimore City. Using 1,914 samples of known exposure status, we developed an algorithm to differentiate previously infected, vaccinated, and unexposed individuals using a combination of antibody assays. We applied this testing algorithm to 4,360 samples from ED patients obtained in the spring of 2020 and 2021. Using multinomial logistic regression, we determined factors associated with infection and vaccination. For the algorithm, sensitivity and specificity for identifying vaccinated individuals were 100% and 99%, respectively, and 84% and 100% for previously infected individuals. Among the ED subjects, seroprevalence to SARS-CoV-2 increased from 2% to 24% between April 2020 and March 2021. Vaccination prevalence rose to 11% by mid-March 2021. Marked differences in burden of disease and vaccination coverage were seen by sex, race, and ethnicity. Hispanic patients, though accounting for 7% of the study population, had the highest relative burden of disease (17% of total infections) but with similar vaccination rates. Women and white individuals were more likely to be vaccinated than men or Black individuals. Individuals previously infected with SARS-CoV-2 can often be differentiated from vaccinated individuals using a serologic testing algorithm. The utility of this algorithm can aid in monitoring SARS-CoV-2 exposure and vaccination uptake frequencies and can potentially reflect gender, race, and ethnic health disparities.

Indexed as

COVID-19SARS-CoV-2Emergency Service, HospitalFemaleHumansMaleSeroepidemiologic StudiesWhite PeopleCOVID-19 vaccination prevalenceemergency departmentfactors associated with SARS-CoV-2 infectionseroprevalence of SARS-CoV-2 antibody

Identifiers

PMID35044204
PMCPMC8925900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.